)

Malgorzata Rogalska
Analyst,
Ysios Capital
Based in Barcelona, Malgorzata joined Ysios Capital in 2022 as an Investment Analyst, bringing over 15 years of experience in life sciences. Her scientific background spans RNA therapeutics, gene regulation, and genetic diseases. Prior to joining the firm, she was a senior researcher at the Centre for Genomic Regulation (CRG) in Barcelona. She has authored 17 high-impact publications, including first-author papers in Nature and Science, and has been awarded the Marie Curie and Juan de la Cierva fellowships. Malgorzata holds a PhD in Molecular Biology from ICGEB/University of Cambridge and degrees in Biotechnology from the Technical University of Lodz
Sessions
-
02-Sep-2025Partnering roomPanel: What do investors really look for in advanced therapy startups?
-
04-Sep-2025PlenaryInnovation exchange
-
04-Sep-2025PlenaryPanel: The reality of raising funds for CGT startups